Stockscreener 앱 받기
113.60
1.99%
-2.31
시간 외 거래:
113.60
전일 마감가:
$115.91
열려 있는:
$116.29
하루 거래량:
1.47M
Relative Volume:
1.49
시가총액:
$6.41B
수익:
$738.26M
순이익/손실:
$48.89M
주가수익비율:
131.41
EPS:
0.8645
순현금흐름:
$91.69M
1주 성능:
-9.56%
1개월 성능:
-5.41%
6개월 성능:
-28.11%
1년 성능:
-15.05%
1일 변동 폭
$113.26
$119.01
1주일 범위
$113.26
$131.53
52주 변동 폭
$109.50
$175.77
Repligen Corp Stock (RGEN) Company Profile
명칭
Repligen Corp
전화
(781) 449-9560
주소
41 SEYON STREET, WALTHAM, MA
Compare RGEN vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
113.60 | 6.54B | 738.26M | 48.89M | 91.69M | 0.8645 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-17 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-01 | 개시 | HSBC Securities | Buy |
| 2025-09-22 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-29 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | 개시 | Evercore ISI | In-line |
| 2025-02-10 | 개시 | TD Cowen | Buy |
| 2024-12-17 | 개시 | Canaccord Genuity | Hold |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-06-18 | 개시 | Guggenheim | Neutral |
| 2023-12-04 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-07-20 | 개시 | Wells Fargo | Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-03-28 | 개시 | The Benchmark Company | Buy |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2021-10-14 | 개시 | Exane BNP Paribas | Outperform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-23 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-11-01 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | 개시 | SVB Leerink | Outperform |
| 2019-08-28 | 재확인 | First Analysis Sec | Outperform |
| 2019-08-23 | 재개 | Stephens | Overweight |
| 2019-07-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | 업그레이드 | CL King | Neutral → Buy |
| 2018-11-12 | 다운그레이드 | CL King | Buy → Neutral |
| 2018-09-26 | 개시 | H.C. Wainwright | Neutral |
| 2017-12-08 | 개시 | Citigroup | Buy |
| 2017-12-05 | 개시 | JP Morgan | Overweight |
| 2017-11-13 | 개시 | CL King | Buy |
| 2017-10-02 | 업그레이드 | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | 개시 | William Blair | Outperform |
| 2017-02-13 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
Repligen Corp 주식(RGEN)의 최신 뉴스
Barclays Maintains an “Overweight Rating” on Repligen Corporation (RGEN) - Yahoo Finance UK
Repligen Q1 2026 slides: revenue jumps 15%, China sales double - Investing.com
Earnings call transcript: Repligen’s Q1 2026 results exceed expectations - Investing.com
Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus
Repligen (RGEN) director adds 2,434 shares via option exercise - Stock Titan
Repligen (RGEN) CPO has 334 RSU shares withheld to cover taxes - Stock Titan
Investors can watch Repligen CFO live from a May 12 healthcare conference - Stock Titan
Repligen (NASDAQ: RGEN) posts Q1 2026 growth but books Polymem sale loss - Stock Titan
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises - Yahoo Finance
Repligen Corporation (NASDAQ:RGEN) Q1 2026 Earnings Call Transcript - Insider Monkey
Repligen Reshapes Operations And China Reach As Valuation Signals Upside - Yahoo Finance
Repligen Q1 Earnings Call Highlights - Yahoo Finance
Repligen Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Repligen (RGEN) Shares Skyrocket, What You Need To Know - Barchart.com
Repligen (RGEN) Q1 2026 Earnings Call Transcript - The Globe and Mail
Repligen Q1 2026 slides: analytics surge drives 23% EPS growth - Investing.com
Earnings call transcript: Repligen beats Q1 2026 forecasts, stock rises - Investing.com
Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Repligen Corp (NASDAQ:RGEN) Sees Pre-Market Gain After Q1 Earnings Beat Offsets Slight Revenue Miss - ChartMill
Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat Estimates - Yahoo Finance
Q1 2026 Repligen Corp Earnings Call Transcript - GuruFocus
Repligen: Q1 Earnings Snapshot - Barchart.com
REPLIGEN ($RGEN) Releases Q1 2026 Earnings - Quiver Quantitative
Repligen (NASDAQ: RGEN) posts 15% Q1 revenue growth and lifts 2026 EPS view - Stock Titan
Repligen raises 2026 profit target after $194M first quarter - Stock Titan
Repligen in the spotlight: Quarterly earnings test growth outlook - Investing.com
Repligen in the spotlight: Quarterly earnings test growth outlook By Investing.com - Investing.com South Africa
Repligen (RGEN) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Repligen Corporation $RGEN Shares Sold by Vanguard Group Inc. - MarketBeat
Repligen Corporation $RGEN Holdings Raised by Artemis Investment Management LLP - MarketBeat
Repligen Corporation (NASDAQ:RGEN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Repligen Corp expected to post earnings of 39 cents a shareEarnings Preview - TradingView
Conestoga Capital Advisors LLC Buys 101,062 Shares of Repligen Corporation $RGEN - MarketBeat
RGEN SEC FilingsRepligen 10-K, 10-Q, 8-K Forms - Stock Titan
RGEN Repligen Corporation shares rise 4.6 percent after Q4 2025 EPS beats consensus estimates by 9.3 percent.Hot Momentum Watchlist - newser.com
Delta Investment Management LLC Reduces Stake in Repligen Corporation $RGEN - MarketBeat
Is Repligen (RGEN) Starting To Look Attractive After Its Sharp Share Price Pullback - Yahoo Finance
Is Repligen Corp (RGEN) a Bargain After 3.7% Drop? GF Value Says Undervalued - GuruFocus
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Tempered Forward Expectations Hurt Repligen Corp. (RGEN) in Q1 - Yahoo Finance
Repligen Corporation (RGEN) Cash Flow Analysis | Q4 2025: Better Than ExpectedFast Rising Picks - newser.com
Impax Asset Management Group plc Sells 289,853 Shares of Repligen Corporation $RGEN - MarketBeat
A Look at Repligen Corp (RGEN) After 3.1% Gain -- GF Value $173. - GuruFocus
Repligen slides 8.3% as CEO share sale disclosure weighs on sentiment - Quiver Quantitative
Repligen Corporation stock hits 52-week low at 109.66 USD - Investing.com
Repligen Corporation stock hits 52-week low at 109.66 USD By Investing.com - Investing.com Canada
M&T Bank Corp Purchases New Holdings in Repligen Corporation $RGEN - MarketBeat
Why Repligen (RGEN) Shares Are Plunging Today - Yahoo Finance
Repligen Corp (RGEN) Stock Down 6.2% -- Now Undervalued? GF Scor - GuruFocus
Insider Sell: Olivier Loeillot Sells Shares of Repligen Corp (RG - GuruFocus
Repligen CEO Loeillot sells $536,480 in company stock By Investing.com - Investing.com India
Repligen Corp (RGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
3.17%
자본화:
|
볼륨(24시간):